The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein

PLoS Pathogens

Volumn 6, Issue 9, 2010, Pages

  Wang, Jingang ^a   Zhou, Dan ^a   Prabhu, Anjali ^a   Schlegel, Richard ^a   Yuan, Hang ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E7; RETINOBLASTOMA PROTEIN; MESSENGER RNA; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CANINE ORAL PAPILLOMAVIRUS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; GAMMAPAPILLOMAVIRUS; GENE SEQUENCE; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN MOTIF; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; AMINO ACID SEQUENCE; ANIMAL; BONE TUMOR; CHEMISTRY; DOG; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; OSTEOSARCOMA; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR CELL CULTURE; VIROLOGY; WESTERN BLOTTING;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BLOTTING, WESTERN; BONE NEOPLASMS; DOGS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 78149322677     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001089     Document Type: Article

References (42)

1. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
2. Stark A, Gregoire L, Pilarski R, Zarbo A, Gaba A, et al. (2008) Human papillomavirus, cervical cancer and women's knowledge. Cancer Detect Prev.
3. Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7: 11-22.
4. McLaughlin-Drubin ME, Munger K (2009) The human papillomavirus E7 oncoprotein. Virology 384: 335-344.
5. Howie HL, Katzenellenbogen RA, Galloway DA (2009) Papillomavirus E6 proteins. Virology 384: 324-334.
6. Huh K, Zhou X, Hayakawa H, Cho JY, Libermann TA, et al. (2007) Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol 81: 9737-9747.
7. Boulet G, Horvath C, Vanden Broeck D, Sahebali S, Bogers J (2007) Human papillomavirus: E6 and E7 oncogenes. Int J Biochem Cell Biol 39: 2006-2011.
8. Figge J, Webster T, Smith TF, Paucha E (1988) Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins. J Virol 62: 1814-1818.
9. Edmonds C, Vousden KH (1989) A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol 63: 2650-2656.
10. Phelps WC, Munger K, Yee CL, Barnes JA, Howley PM (1992) Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol 66: 2418-2427.
11. Jewers RJ, Hildebrandt P, Ludlow JW, Kell B, McCance DJ (1992) Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J Virol 66: 1329-1335.
12. Storey A, Almond N, Osborn K, Crawford L (1990) Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein. J Gen Virol 71 (Pt 4): 965-970.
13. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, et al. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Embo J 8: 4099-4105.
14. Liu X, Clements A, Zhao K, Marmorstein R (2006) Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem 281: 578-586.
15. Helt AM, Galloway DA (2001) Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J Virol 75: 6737-6747.
16. Dyson N, Guida P, Munger K, Harlow E (1992) Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66: 6893-6902.
17. Clemens KE, Brent R, Gyuris J, Munger K (1995) Dimerization of the human papillomavirus E7 oncoprotein in vivo. Virology 214: 289-293
18. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, et al. (1999) The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. Embo J 18: 2449-2458.
19. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, et al. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20: 7888-7898.
20. Huang PS, Patrick DR, Edwards G, Goodhart PJ, Huber HE, et al. (1993) Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol 13: 953-960.
21. Wu EW, Clemens KE, Heck DV, Munger K (1993) The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol 67: 2402-2407.
22. Rector A, Bossart GD, Ghim SJ, Sundberg JP, Jenson AB, et al. (2004) Characterization of a novel close-to-root papillomavirus from a Florida manatee by using multiply primed rolling-circle amplification: Trichechus manatus latirostris papillomavirus type 1. J Virol 78: 12698-12702.
23. Moreno-Lopez J, Ahola H, Stenlund A, Osterhaus A, Pettersson U (1984) Genome of an avian papillomavirus. J Virol 51: 872-875.
24. Yuan H, Estes PA, Chen Y, Newsome J, Olcese VA, et al. (2001) Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J Virol 75: 7848-7853.
25. Stanley MA, Moore RA, Nicholls PK, Santos EB, Thomsen L, et al. (2001) Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs. Vaccine 19: 2783-2792.
26. Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, et al. (2005) Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res 65: 10854-10861.
27. Yuan H, Ghim S, Newsome J, Apolinario T, Olcese V, et al. (2007) An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus. Virology 359: 28-36.
28. Goldschmidt MH, Kennedy JS, Kennedy DR, Yuan H, Holt DE, et al. (2006) Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J Virol 80: 6621-6628.
29. Sparkowski J, Anders J, Schlegel R (1994) Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J Virol 68: 6120-6123.
30. Schlegel R, Phelps WC, Zhang YL, Barbosa M (1988) Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. Embo J 7: 3181-3187
31. Yuan H, Veldman T, Rundell K, Schlegel R (2002) Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J Virol 76: 10685-10691.
32. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
33. Jones RE, Wegrzyn RJ, Patrick DR, Balishin NL, Vuocolo GA, et al. (1990) Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. J Biol Chem 265: 12782-12785.
34. Forng RY, Atreya CD (1999) Mutations in the retinoblastoma protein-binding LXCXE motif of rubella virus putative replicase affect virus replication. J Gen Virol 80 (Pt 2): 327-332.
35. Munger K, Halpern AL (1997) hpv e7 primary structure and biological properties.
36. Patrick DR, Oliff A, Heimbrook DC (1994) Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. J Biol Chem 269: 6842-6850.
37. Stoppler H, Stoppler MC, Adduci A, Koval D, Schlegel R (1996) The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability. Virology 217: 542-553.
38. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, et al. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78: 11451-11460.
39. de Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H (2004) Classification of papillomaviruses. Virology 324: 17-27.
40. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
41. Felsani A, Mileo AM, Paggi MG (2006) Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25: 5277-5285.
42. Lange CE, Tobler K, Ackermann M, Panakova L, Thoday KL, et al. (2009) Three novel canine papillomaviruses support taxonomic clade formation. J Gen Virol.